EGFR and non-small cell lung carcinoma: Moreover, co-treatment with Cur and gefitinib significantly inactivates EGFR by retarding Sp1, influencing the interaction between Sp1 and HDAC1 and markedly promoting autophagy and autophagy-mediated apoptosis in resistant NSCLC cells [94].